METHRO II: Dose-response study of the novel oral, direct thrombin inhibitor, H 376/95, and its subcutaneous formulation melagatran, compared with dalteparin as thromboembolic prophylaxis after total hip replacement or total knee replacement - Eriksson, BI; Lindbratt, S; Kälabo, P (Haemostasis, 2000)
et al.